KLRK1 and B-cell non-Hodgkin lymphoma: Conversely, spontaneous tumor development in genetically engineered mouse models of prostate cancer and B cell lymphomas are accelerated in NKG2D-deficient mice [11], reflecting the critical role of the NKG2D pathway in cancer immunosurveillance.